Insulin activates Na<sup>+</sup>/H<sup>+</sup>exchanger 3: biphasic response and glucocorticoid dependence
Jelena Klisic(University of Zurich), Patrice M. Ambühl(Triemli Hospital), Orson W. Moe(Io Therapeutics (United States)), Livia Reyes(University of Zurich), Vera Nief(University of Zurich), Daniel G. Fuster(University of Bern), Ming Chang Hu(Beijing Luhe Hospital Affiliated to Capital Medical University)
Cited by 175
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
|Kidney International|2020|502
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394